Published in Ont Health Technol Assess Ser on December 01, 2010
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Value Health (2012) 1.16
The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment. Oncologist (2015) 0.94
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment. Curr Oncol (2014) 0.92
Patients' perceptions of gene expression profiling in breast cancer treatment decisions. Curr Oncol (2014) 0.89
Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews. Genet Med (2014) 0.82
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? Genet Med (2015) 0.81
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer. BMC Cancer (2012) 0.81
Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine. World J Clin Oncol (2014) 0.81
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer. Oncol Lett (2015) 0.78
Clinicians' expectations for gene-driven cancer therapy. Clin Med Insights Oncol (2014) 0.75
Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists. Curr Oncol (2017) 0.75
Multigene expression profile testing in breast cancer: is there a role for family physicians? Curr Oncol (2017) 0.75
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol (2006) 16.25
Concordance among gene-expression-based predictors for breast cancer. N Engl J Med (2006) 13.50
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst (2009) 7.95
Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol (2004) 5.29
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol (2010) 4.81
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol (2010) 4.75
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol (2008) 4.42
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst (1997) 4.32
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res (2006) 4.28
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol (2005) 4.03
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol (2010) 3.79
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (2010) 3.54
Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med (2008) 3.32
Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J Clin Oncol (2009) 3.08
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem (2007) 3.05
Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer. Am J Manag Care (2005) 2.37
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer (2007) 2.03
Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer. J Oncol Pract (2007) 1.97
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res (2005) 1.78
Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? Am J Surg (2008) 1.73
Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol (2008) 1.72
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res (2005) 1.64
Clinical trial designs for prospective validation of biomarkers. Am J Pharmacogenomics (2005) 1.43
Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer. Oncologist (2010) 1.42
Impact of gene expression profiling tests on breast cancer outcomes. Evid Rep Technol Assess (Full Rep) (2007) 1.35
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat (2007) 1.31
Clinical trial designs for predictive biomarker validation: one size does not fit all. J Biopharm Stat (2009) 1.30
Predictive biomarker validation in practice: lessons from real trials. Clin Trials (2010) 1.24
Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer (2010) 1.23
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. Cancer Invest (2010) 1.18
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat (2008) 1.12
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat (2006) 1.08
Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study. Cancer (2008) 0.93
Complementary value of the Ki-67 proliferation index to the oncotype DX recurrence score. Int J Surg Pathol (2009) 0.88
Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer. PLoS One (2009) 0.86
21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients. Breast (2009) 0.85
Stage I breast cancer in a regional oncology practice in Israel 2002-2006: clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients. Breast (2009) 0.80
Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser (2008) 1.10
Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2009) 1.03
Behavioural interventions for type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.98
Home telemonitoring for type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.95
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2010) 0.95
Intrathecal baclofen pump for spasticity: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.94
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2009) 0.92
Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis. Ont Health Technol Assess Ser (2011) 0.91
The Falls/Fractures Economic Model in Ontario Residents Aged 65 Years and Over (FEMOR). Ont Health Technol Assess Ser (2008) 0.91
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.90
Continuity of care to optimize chronic disease management in the community setting: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.90
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.90
Caregiver- and patient-directed interventions for dementia: an evidence-based analysis. Ont Health Technol Assess Ser (2008) 0.90
Physiotherapy rehabilitation after total knee or hip replacement: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.89
Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.89
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Epilepsy surgery: an evidence summary. Ont Health Technol Assess Ser (2012) 0.88
Coil embolization for intracranial aneurysms: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.88
Arthroscopic lavage and debridement for osteoarthritis of the knee: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.87
KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis. Ont Health Technol Assess Ser (2010) 0.87
Management of chronic pressure ulcers: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.87
Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.87
Spinal cord stimulation for neuropathic pain: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.87
Specialized nursing practice for chronic disease management in the primary care setting: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.86
Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis. Ont Health Technol Assess Ser (2011) 0.86
Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.86
Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2014) 0.85
Screening and management of depression for adults with chronic diseases: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.85
Electronic tools for health information exchange: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.85
Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.85
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.84
Sacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.84
Balloon kyphoplasty: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.84
In-home care for optimizing chronic disease management in the community: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.84
Bispectral index monitor: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.84
The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis. Ont Health Technol Assess Ser (2014) 0.84
Advanced electrophysiologic mapping systems: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.84
Negative pressure wound therapy: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.84
Limbal stem cell transplantation: an evidence-based analysis. Ont Health Technol Assess Ser (2008) 0.83
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ont Health Technol Assess Ser (2016) 0.83
Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.83
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Pressure ulcer prevention: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.82
Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.82
Total knee replacement: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Oral appliances for obstructive sleep apnea: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.82
Diabetes strategy evidence platform: a summary of evidence-based analyses. Ont Health Technol Assess Ser (2009) 0.82
Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.82
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.82
Endovascular repair of descending thoracic aortic aneurysm: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.81
Routine eye examinations for persons 20-64 years of age: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.81
Community-based care for the specialized management of heart failure: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.81
Vitamin B12 and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser (2013) 0.81
Ablation for atrial fibrillation: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.81
Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.80
Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses. Ont Health Technol Assess Ser (2009) 0.80
Metal-on-Metal Total Hip Resurfacing Arthroplasty: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.80
Air cleaning technologies: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.80
Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.80
Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews. Ont Health Technol Assess Ser (2010) 0.80
Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis. Ont Health Technol Assess Ser (2012) 0.80
Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.80
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.79
Bone morphogenetic proteins & spinal surgery for degenarative disc disease: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.79
Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.79
Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2015) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.79
Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis. Ont Health Technol Assess Ser (2003) 0.79
Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.79
Portable bladder ultrasound: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.79
Community-based care for chronic wound management: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.79
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.78
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.78
Video laryngoscopy for tracheal intubation: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.78
Primary Angioplasty and Thrombolysis for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence Update. Ont Health Technol Assess Ser (2010) 0.78
Anal dysplasia screening: an evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.78
Thermal balloon endometrial ablation for dysfunctional uterine bleeding: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.78
Bariatric surgery: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.78
Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses. Ont Health Technol Assess Ser (2010) 0.78
Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.78
Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.78
Artificial discs for lumbar and cervical degenerative disc disease -update: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.78
Pyrocarbon finger joint implant: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.78
Radio frequency ablation for primary liver cancer: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.78
Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.77
Community-based care for the management of type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.77
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.77
Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.77
Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.77
Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.77
Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.76
Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.76
Low-density lipoprotein apheresis: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.76
Gastric electrical stimulation: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.76
In vitro fertilization and multiple pregnancies: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.76
Social isolation in community-dwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser (2008) 0.76
Computer-assisted surgery using telemanipulators: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.76
Hyperbaric oxygen therapy for non-healing ulcers in diabetes mellitus: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.76